Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul J Hampel

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Blood Cancer Journal|December 21, 2022
Correction: Chronic lymphocytic leukemia treatment algorithm 2022Paul J Hampel, Sameer A Parikh
Blood Cancer Journal|November 29, 2022
Chronic lymphocytic leukemia treatment algorithm 2022Paul J Hampel, Sameer A Parikh
American Journal of Hematology|January 24, 2023
BTKi bonanza in CLL/SLL: Sorting out the differencesPaul J Hampel, Sameer A Parikh
Leukemia & Lymphoma|January 7, 2021
Incorporating molecular biomarkers into the continuum of care in chronic lymphocytic leukemiaPaul J Hampel, Sameer A Parikh, Timothy G Call
Blood Reviews|February 13, 2022
CLL update 2022: A continuing evolution in careNeil E Kay, Paul J Hampel, Daniel L Van Dyke, et al.
Journal of Biomedical Materials Research. Part A|August 21, 2010
Mono-dispersed bioactive glass nanospheres: preparation and effects on biomechanics of mammalian cellsZhongkui Hong, Gisela M Luz, Paul J Hampel, et al.
Human Pathology|April 13, 2026
Next-Generation Sequencing for Lymphoid Neoplasms: Real-World Utility from a Clinical AssayChuan Chen, Cody J Artymiuk, Tanya L Schwab, et al.
Blood Cancer Journal|February 23, 2022
Isolated anemia in patients with large granular lymphocytic leukemia (LGLL)Youssef Salama, Fang Zhao, Jennifer L Oliveira, et al.
JCO Oncology Practice|February 26, 2024
Rechallenge With High-Dose Methotrexate After Treatment With Glucarpidase in Adult Patients With LymphomaHuong L Truong, Jason N Barreto, Kristin C Mara, et al.
Blood Advances|September 18, 2020
Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinibPaul J Hampel, Hua-Jay J Cherng, Timothy G Call, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Blood Cancer Journal|December 21, 2022
Correction: Chronic lymphocytic leukemia treatment algorithm 2022Paul J Hampel, Sameer A Parikh
Blood Cancer Journal|November 29, 2022
Chronic lymphocytic leukemia treatment algorithm 2022Paul J Hampel, Sameer A Parikh
American Journal of Hematology|January 24, 2023
BTKi bonanza in CLL/SLL: Sorting out the differencesPaul J Hampel, Sameer A Parikh
Leukemia & Lymphoma|January 7, 2021
Incorporating molecular biomarkers into the continuum of care in chronic lymphocytic leukemiaPaul J Hampel, Sameer A Parikh, Timothy G Call
Blood Reviews|February 13, 2022
CLL update 2022: A continuing evolution in careNeil E Kay, Paul J Hampel, Daniel L Van Dyke, et al.
Journal of Biomedical Materials Research. Part A|August 21, 2010
Mono-dispersed bioactive glass nanospheres: preparation and effects on biomechanics of mammalian cellsZhongkui Hong, Gisela M Luz, Paul J Hampel, et al.
Human Pathology|April 13, 2026
Next-Generation Sequencing for Lymphoid Neoplasms: Real-World Utility from a Clinical AssayChuan Chen, Cody J Artymiuk, Tanya L Schwab, et al.
Blood Cancer Journal|February 23, 2022
Isolated anemia in patients with large granular lymphocytic leukemia (LGLL)Youssef Salama, Fang Zhao, Jennifer L Oliveira, et al.
JCO Oncology Practice|February 26, 2024
Rechallenge With High-Dose Methotrexate After Treatment With Glucarpidase in Adult Patients With LymphomaHuong L Truong, Jason N Barreto, Kristin C Mara, et al.
Blood Advances|September 18, 2020
Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinibPaul J Hampel, Hua-Jay J Cherng, Timothy G Call, et al.
Pageof 5